Clinical trials
Completed Respiratory Tract Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| FDA Office of Orphan Products Development | 4 |
| Universidade Metodista de Piracicaba | 3 |
| National Center for Research Resources (NCRR) | 2 |
| Olympus Corporation of the Americas | 2 |
| University of California, Los Angeles | 2 |
| Ain Shams University | 1 |
| Albert Einstein College of Medicine | 1 |
| Basque Health Service | 1 |
| Brigham and Women's Hospital | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Tract Diseases | 55 |
| Lung Diseases | 16 |
| Rare Diseases | 12 |
| Cystic Fibrosis | 8 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Genetic Diseases, Inborn | 7 |
| Lung Diseases, Obstructive | 7 |
| Asthma | 6 |
| Bronchial Diseases | 4 |
| Pathologic Processes | 4 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.